Inventor · disambiguated record
Qiangang Zheng
Also filed as: ZHENG QIANGANG
6 granted patents·11 pending applications·6 citations·filing 2016–2025
71Inventor score
Files withETERN BIOPHARMA SHANGHAI CO LTD10NOVARTIS AG3MOTZ GREGORY2ABBVIE INC1SHANGHAI HAIHE PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
17 records- 0189US10844079B2Spiro aromatic ring compound and application thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2020·Granted Nov 24, 2020·4 cites·2 claims
- 0284US11685748B2Spiro aromatic ring compound and application thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2020·Granted Jun 27, 2023·2 cites·12 claims
- 0374US12441743B2Spiro aromatic ring compound and use thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2023·Granted Oct 14, 2025·0 cites·18 claims
- 0456US2025177408A1Inhibitor of interaction between yap/taz and tead, preparation thereof, pharmaceutical composition thereof and use thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0555US2025382621A1Immune effector cell therapies with enhanced efficacyNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0654US2025154127A1Bicyclic heteroaryl compounds and uses thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0751US2024101535A1Dihydroisoquinolinone derivative and application thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0850US2023339975A1Crystalline form of shp2 inhibitor, and composition thereof, preparation method therefor, and use thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0949US2024150301A1Methods of modulating androgen receptor condensatesETERN BIOPHARMA SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1045US2019000880A1Immune effector cell therapies with enhanced efficacyMOTZ GREGORY·Filed 2016·Application pending·0 cites
- 1144US2022298143A1Pyrazole Derivatives for FGFR Inhibitor and Preparation Method ThereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2020·Application pending·0 cites
- 1241US2023242551A1Isotope-substituted spiro aromatic ring compound and application thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1337US10604502B2Substituted 5-cyanoindole compounds and uses thereofNOVARTIS AG·Filed 2018·Granted Mar 31, 2020·0 cites·18 claims
- 1436US2019119200A1Tertiary amides and method of useABBVIE INC·Filed 2017·Application pending·0 cites
- 1535US10682352B2Compound having mutant IDH inhibitory activity, preparation method and use thereofSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 16, 2020·0 cites·15 claims
- 1635US10590079B2Cyano-substituted indoles as LSD1 inhibitorsNOVARTIS AG·Filed 2017·Granted Mar 17, 2020·0 cites·16 claims
- 1735US2019298715A1Immune effector cell therapies with enhanced efficacyMOTZ GREGORY·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qiangang Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →